Burlington software maker Exa Corp. and Waltham biotech firm Tesaro Inc. are both expected to make their Wall Street debuts next week.
The 21-year-old Exa, which makes software used to test vehicle aerodynamics, will offer shares at prices between $11 and $13, according to a filing earlier this week with the Securities and Exchange Commission. Its initial public offering on the Nasdaq exchange could raise $75 million.
Tesaro is also expected to open on the Nasdaq and raise $81 million. The two-year-old biotech company will price shares between $12 and $15, according to its filing.
The two companies could be among the first initial offerings on the Nasdaq since Facebook Inc. went public in May, according to Renaissance Capital, a Greenwich, Conn., investment advisory firm.
Exa Corp. reported $45.9 million in revenue for its 2012 fiscal year that ended Jan. 31, a 21 percent increase over the same period last year. The company’s stock symbol will be EXA.
Tesaro does not have revenues to date, and is developing drugs intended to reduce cancer treatment side effects. Its stock symbol will be TSRO.